English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1256]
News [2395]
Articles [92]
Editorials [4]
Conferences [118]
elearning [25]
Chemoradiotherapy patients are more likely to have multiple infections and encouraged to start antibiotic therapy immediately for early intervention
Chemoradiotherapy patients are more likely to have multiple infections and encouraged to start antibiotic therapy...
Minimising immunotherapy’s potentially harmful side effects
Minimising immunotherapy’s potentially harmful side effects
Studies help explain why some prostate cancers become resistant to hormone therapy
Studies help explain why some prostate cancers become resistant to hormone therapy
SABCS 2023: Patients with HR-positive breast cancer may use fertility preservation and assisted reproductive technologies without increased risk of recurrence
SABCS 2023: Patients with HR-positive breast cancer may use fertility preservation and assisted reproductive...
Lesbian, gay, and bisexual survivors of adolescent and young adult cancers often have chronic health conditions
Lesbian, gay, and bisexual survivors of adolescent and young adult cancers often have chronic health conditions
A novel targeted molecular therapy for drug-resistant biliary tract cancer
A novel targeted molecular therapy for drug-resistant biliary tract cancer
Fast-tracked cancer drug candidate causes substantial levels of mutations and must be investigated for risk of secondary cancer
Fast-tracked cancer drug candidate causes substantial levels of mutations and must be investigated for risk of...
FDA approves pembrolizumab with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma
FDA approves pembrolizumab with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma
FDA approves capivasertib with fulvestrant for breast cancer
FDA approves capivasertib with fulvestrant for breast cancer
187 new genetic variants linked to prostate cancer
187 new genetic variants linked to prostate cancer
<1...89101112...240>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top